Jonosteril Na 100 Kohlenhydratfrei

Magnesium chloride hexahydrate, potassium chloride, sodium chloride and calcium chloride dihydrate, the active ingredients in Jonosteril Na 100 Kohlenhydratfrei, are an electrolyte solution presented as a sterile solution for intravenous use. It provides sodium, potassium, calcium, magnesium and chloride ions to restore and maintain fluid and electrolyte balance in patients requiring replacement therapy.

GNH USA supplies Jonosteril Na 100 Kohlenhydratfrei as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Jonosteril Na 100 is an electrolyte solution used in clinical situations where fluid and electrolyte balance must be restored or maintained. - Fluid replacement: supplies essential electrolytes and water to patients with acute volume loss. - Electrolyte replenishment: corrects deficits of sodium, potassium, calcium and magnesium during illness or surgery. - Critical care maintenance: supports electrolyte homeostasis in intensive care or peri‑operative settings. - Dehydration management: rehydrates patients with combined fluid and electrolyte depletion.

Jonosteril Na 100 may be associated with infusion‑related reactions and electrolyte‑related adverse events.

Common Side Effects: - Mild hypernatremia: transient elevation of serum sodium. - Hyperkalemia: modest increase in serum potassium. - Local irritation: pain or erythema at the infusion site. - Hypocalcemia: occasional drop in calcium levels. - Headache or dizziness during rapid infusion.

Serious or Rare Side Effects: - Severe hypermagnesemia: can cause hypotension, bradycardia, respiratory depression. - Cardiac arrhythmias: due to electrolyte imbalance. - Anaphylactoid reaction: rare hypersensitivity to solution components. - Metabolic alkalosis: from excessive chloride removal. - Volume overload: pulmonary edema in patients with compromised cardiac function.

Jonosteril Na 100 should be used with clinical monitoring and appropriate patient assessment. - Renal impairment: adjust infusion rate and monitor electrolytes closely. - Cardiac disease: avoid rapid infusion that may precipitate arrhythmias. - Fluid overload risk: assess volume status before administration. - Electrolyte disorders: correct existing imbalances prior to infusion. - Compatibility: verify compatibility with other IV medications before co‑administration. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Electrolyte solutions can interact with other medications that affect fluid or electrolyte balance.

Major Interactions (Avoid): - Loop diuretics: may cause excessive potassium loss when combined. - ACE inhibitors/ARBs: increase risk of hyperkalemia. - Calcium channel blockers: additive effects on calcium levels.

Moderate Interactions (Monitor Closely): - Sodium‑containing drugs: monitor for hypernatremia. - Magnesium‑containing antacids: risk of hypermagnesemia. - Blood pressure agents: watch for hypotensive effects due to volume expansion.